Hydroxyzine
Treatment for Interstitial Cystitis
Typical Dosage: 10-50mg daily
Effectiveness
45%
Safety Score
78%
Clinical Trials
20
Participants
1K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
78
DangerousModerateSafe
Treatment Details
Dosage Range
10-50mg daily
Time to Effect
1-2 weeks
Treatment Duration
Lifetime
Evidence Quality
LOWConfidence Score
60%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$500
Side Effect Mgmt:$50
Total Annual:$650
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$10,147/QALY
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$2,166.67
Cost per Remission
$32,500
Prescription Access Economics
Annual Societal Loss per Patient
$2,940
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$250/year
Time Cost
$100/year
Travel + wait time
Insurance Admin Cost
$40/year
Prior auth, claims
Rx Price
$100/year
Potential OTC Price
$50/year
Estimated if OTC available
Early Treatment Benefit
+0.05 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOWMissed Diagnosis Risk
LOWHydroxyzine Outcomes
for Interstitial Cystitis
Efficacy Outcomes
Overall Effectiveness
+45%
Response Rate
+30%
Remission Rate
+2%
Common Side Effects
Drowsiness
+25%
Dry mouth
+15%
Dizziness
+7%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov